Literature DB >> 8971112

Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation.

J R Campodonico1, A M Codori, J Brandt.   

Abstract

This study examined whether neuropsychological changes emerge over time in asymptomatic adults who have the Huntington's disease mutation. We also evaluated whether scores on cognitive tests or psychological symptom scales varied as a function of CAG repeat length or proximity to disease onset. Twenty two healthy "mutation positive" and 37 "mutation negative" adults completed cognitive tests and psychological rating scales before disclosure of their genetic test results and on an annual basis thereafter. Repeated measures ANOVAs analysed differences between the two groups over three assessments. Correlations of cognitive and psychological symptom test scores with estimated number of years to disease onset and CAG repeat length were computed. The two groups did not differ at study entry; nor did they differ in the rate of change over time. Tests of sustained attention and mental speed correlated with estimated years to disease onset, but not with repeat length. As a group, clinically asymptomatic adults with the Huntington's disease mutation do not display neuropsychological deficits when studied over a two year interval. However, persons who are likely nearing clinical onset of Huntington's disease may develop minor deficits in selected cognitive domains before they reach threshold for diagnosis.

Entities:  

Mesh:

Year:  1996        PMID: 8971112      PMCID: PMC486659          DOI: 10.1136/jnnp.61.6.621

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.

Authors:  S T Grafton; J C Mazziotta; J J Pahl; P St George-Hyslop; J L Haines; J Gusella; J M Hoffman; L R Baxter; M E Phelps
Journal:  Ann Neurol       Date:  1990-11       Impact factor: 10.422

2.  Presymptomatic neuropsychological impairment in Huntington's disease.

Authors:  G W Jason; E M Pajurkova; O Suchowersky; J Hewitt; C Hilbert; J Reed; M R Hayden
Journal:  Arch Neurol       Date:  1988-07

3.  The measurement of pessimism: the hopelessness scale.

Authors:  A T Beck; A Weissman; D Lester; L Trexler
Journal:  J Consult Clin Psychol       Date:  1974-12

4.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

5.  The measurement of abnormal movement: methods developed for Huntington's disease.

Authors:  S E Folstein; B Jensen; R J Leigh; M F Folstein
Journal:  Neurobehav Toxicol Teratol       Date:  1983 Nov-Dec

6.  Personal and extrapersonal orientation in Huntington's disease patients and those at risk.

Authors:  F W Bylsma; J Brandt; M E Strauss
Journal:  Cortex       Date:  1992-03       Impact factor: 4.027

7.  Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease.

Authors:  N G Ranen; O C Stine; M H Abbott; M Sherr; A M Codori; M L Franz; N I Chao; A S Chung; N Pleasant; C Callahan
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

8.  Are there neuropsychologic manifestations of the gene for Huntington's disease in asymptomatic, at-risk individuals?

Authors:  M E Strauss; J Brandt
Journal:  Arch Neurol       Date:  1990-08

9.  Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.

Authors:  J Brandt; K A Quaid; S E Folstein; P Garber; N E Maestri; M H Abbott; P R Slavney; M L Franz; L Kasch; H H Kazazian
Journal:  JAMA       Date:  1989-06-02       Impact factor: 56.272

10.  The Cognitive Failures Questionnaire (CFQ) and its correlates.

Authors:  D E Broadbent; P F Cooper; P FitzGerald; K R Parkes
Journal:  Br J Clin Psychol       Date:  1982-02
View more
  20 in total

Review 1.  Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review.

Authors:  R Timman; T Stijnen; A Tibben
Journal:  J Med Genet       Date:  2004-07       Impact factor: 6.318

2.  The right to ignore genetic status of late onset genetic disease in the genomic era; Prenatal testing for Huntington disease as a paradigm.

Authors:  A Erez; K Plunkett; V R Sutton; A L McGuire
Journal:  Am J Med Genet A       Date:  2010-07       Impact factor: 2.802

3.  Suicidal ideation in Huntington disease: the role of comorbidity.

Authors:  Heather H Wetzel; Carissa R Gehl; Lisa Dellefave-Castillo; Judith F Schiffman; Kathleen M Shannon; Jane S Paulsen
Journal:  Psychiatry Res       Date:  2011-05-24       Impact factor: 3.222

4.  Movement sequencing in Huntington disease.

Authors:  Nellie Georgiou-Karistianis; Jeffrey D Long; Spencer G Lourens; Julie C Stout; James A Mills; Jane S Paulsen
Journal:  World J Biol Psychiatry       Date:  2014-03-28       Impact factor: 4.132

5.  Indexing disease progression at study entry with individuals at-risk for Huntington disease.

Authors:  Ying Zhang; Jeffrey D Long; James A Mills; John H Warner; Wenjing Lu; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-19       Impact factor: 3.568

6.  Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Authors:  Jurgen Lemiere; Marleen Decruyenaere; Gery Evers-Kiebooms; Erik Vandenbussche; Rene Dom
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

7.  Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease.

Authors:  Andrea C Solomon; Julie C Stout; Marjorie Weaver; Sarah Queller; Allison Tomusk; Kathryn Burr Whitlock; Siu L Hui; Jeanine Marshall; Jacqueline Gray Jackson; Eric R Siemers; Xabier Beristain; Joanne Wojcieszek; Tatiana Foroud
Journal:  Mov Disord       Date:  2008-10-15       Impact factor: 10.338

8.  Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness.

Authors:  Robert Christian Wolf; Georg Grön; Fabio Sambataro; Nenad Vasic; Nadine Donata Wolf; Philipp Arthur Thomann; Carsten Saft; G Bernhard Landwehrmeyer; Michael Orth
Journal:  Hum Brain Mapp       Date:  2011-08-25       Impact factor: 5.038

9.  Cognitive reserve and brain reserve in prodromal Huntington's disease.

Authors:  Aaron Bonner-Jackson; Jeffrey D Long; Holly Westervelt; Geoffrey Tremont; Elizabeth Aylward; Jane S Paulsen
Journal:  J Int Neuropsychol Soc       Date:  2013-05-23       Impact factor: 2.892

10.  Cognitive decline in prodromal Huntington Disease: implications for clinical trials.

Authors:  Jane S Paulsen; Megan M Smith; Jeffrey D Long
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.